Wuhan YZY Biopharma Market Cap

Wuhan YZY Biopharma has a market cap or net worth of 736.63 million as of July 9, 2026. Its market cap has decreased by -27.20% in one year.

Market Cap

736.63M

Enterprise Value

767.44M

Revenue

74.40M

Ranking

n/a

PE Ratio

n/a

Stock Price

3.80

Market Cap Chart

Since September 25, 2023, Wuhan YZY Biopharma's market cap has decreased from 3.09B to 736.63M, a decrease of -76.15%. That is a compound annual growth rate of -40.18%.

Market Cap History

Date	Market Cap	% Change
Jul 9, 2026	736.63M	-52.62%
Dec 31, 2025	1.55B	-3.14%
Dec 31, 2024	1.61B	-6.97%
Dec 29, 2023	1.73B	-44.13%
Sep 25, 2023	3.09B	-

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Cutia Therapeutics	1.02B
Cloudbreak Pharma	1.01B
Kintor Pharmaceutical	1.01B
Sunho Biologics	970.43M
Brii Biosciences	822.86M
JW (Cayman) Therapeutics Co.	779.32M
Shanghai Bio-heart Biological Technology	732.69M
3D Medicines	590.21M

Market Cap Rankings